Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Spector, Tim

King'S College London
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 1OT2CA297289-01 Asad Umar, D.V.M., Ph.D.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 3R37CA269649-03S1 Matthew Young, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-03 Rachel Altshuler, Ph.D.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-03 Rachel Altshuler, Ph.D.
Stolley, Melinda R

Medical College Of Wisconsin
United States

Every Day Counts: A lifestyle program for women metastatic breast cancer 5R01CA258759-04 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Storz, Peter

Mayo Clinic Jacksonville
United States

Deiminated molecules as markers for developing pancreatic cancer - A1 5R21CA279916-02 Matthew Young, Ph.D.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 3UG1CA189821-11S1 Vanessa A. White, M.P.H.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 3UG1CA189821-11S1 Vanessa A. White, M.P.H.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 3R01CA278816-03S1 Matthew Young, Ph.D.
Sun, Ju

University Of Minnesota
United States

SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data 4R01CA287413-03 Claire Zhu, Ph.D.
Suter, Melissa J

Massachusetts General Hospital
United States

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy 5R01CA255326-04 Guillermo Marquez, Ph.D.
Svatek, Robert Scott

University Of Texas Hlth Science Center
United States

eRapa for bladder cancer prevention 5R01CA252057-05 Howard L. Parnes, M.D.
Tabung, Fred Kinyuy

Ohio State University
United States

Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients 1R21CA294050-01 Amit Kumar, Ph.D.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials